These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8397449)

  • 1. Reciprocating autocatalytic interactions between platelets and the activation system.
    Ouimet H; Loscalzo J
    Thromb Res; 1993 Jun; 70(5):355-64. PubMed ID: 8397449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics and mechanism of platelet-surface plasminogen activation by tissue-type plasminogen activator.
    Ouimet H; Freedman JE; Loscalzo J
    Biochemistry; 1994 Mar; 33(10):2970-6. PubMed ID: 8130211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelets and plasminogen activation.
    Loscalzo J; Pasche B; Ouimet H; Freedman JE
    Thromb Haemost; 1995 Jul; 74(1):291-3. PubMed ID: 8578474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a) binds to human platelets and attenuates plasminogen binding and activation.
    Ezratty A; Simon DI; Loscalzo J
    Biochemistry; 1993 May; 32(17):4628-33. PubMed ID: 8485140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet activation and subsequent inhibition by plasmin and recombinant tissue-type plasminogen activator.
    Penny WF; Ware JA
    Blood; 1992 Jan; 79(1):91-8. PubMed ID: 1530814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the binding of human tissue-type plasminogen activator to platelets.
    Vaughan DE; Mendelsohn ME; Declerck PJ; Van Houtte E; Collen D; Loscalzo J
    J Biol Chem; 1989 Sep; 264(27):15869-74. PubMed ID: 2550424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets and soluble fibrin promote plasminogen activation causing downregulation of platelet glycoprotein Ib/IX complexes: protection by aprotinin.
    de Haan J; van Oeveren W
    Thromb Res; 1998 Nov; 92(4):171-9. PubMed ID: 9840026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc delays clot lysis by attenuating plasminogen activation and plasmin-mediated fibrin degradation.
    Henderson SJ; Stafford AR; Leslie BA; Kim PY; Vaezzadeh N; Ni R; Fredenburgh JC; Weitz JI
    Thromb Haemost; 2015 Jun; 113(6):1278-88. PubMed ID: 25789495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-molecular-mass and low-molecular-mass kininogens block plasmin-induced platelet aggregation by forming a complex with kringle 5 of plasminogen/plasmin.
    Selim TE; Ghoneim HR; Uknis AB; Colman RW; DeLa Cadena RA
    Eur J Biochem; 1997 Dec; 250(2):532-8. PubMed ID: 9428707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasminogen-induced aggregation of PANC-1 cells requires conversion to plasmin and is inhibited by endogenous plasminogen activator inhibitor-1.
    Deshet N; Lupu-Meiri M; Espinoza I; Fili O; Shapira Y; Lupu R; Gershengorn MC; Oron Y
    J Cell Physiol; 2008 Sep; 216(3):632-9. PubMed ID: 18366077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation.
    Cesarman GM; Guevara CA; Hajjar KA
    J Biol Chem; 1994 Aug; 269(33):21198-203. PubMed ID: 8063741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding and activation of plasminogen on the platelet surface.
    Miles LA; Plow EF
    J Biol Chem; 1985 Apr; 260(7):4303-11. PubMed ID: 3920216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition by tranexamic acid of the conversion of single-chain tissue plasminogen activator to its two chain form by plasmin: the presence on tissue plasminogen activator of a site to bind with lysine binding sites of plasmin.
    Takada A; Takada Y
    Thromb Res; 1989 Sep; 55(6):717-25. PubMed ID: 2551068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dependence of activation of platelets by a plasminogen activator on the evolution of thrombin activity.
    Torr SR; Eisenberg PR; Sobel BE
    Thromb Res; 1991 Nov; 64(4):435-44. PubMed ID: 1724101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trinitrobenzoylated poly(D-lysine) as a stimulator of interactions between plasminogen, plasmin, and tissue-type plasminogen activator.
    Petersen LC; Suenson E
    Biochim Biophys Acta; 1986 Sep; 883(2):313-25. PubMed ID: 2943320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human platelet activation by thrombolytic agents: effects of tissue-type plasminogen activator and urokinase on platelet surface P-selectin expression.
    Kawano K; Aoki I; Aoki N; Homori M; Maki A; Hioki Y; Hasumura Y; Terano A; Arai T; Mizuno H; Ishikawa K
    Am Heart J; 1998 Feb; 135(2 Pt 1):268-71. PubMed ID: 9489975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of plasminogen and tissue plasminogen activator to plasmin-modulated factor X and factor Xa.
    Grundy JE; Lavigne N; Hirama T; MacKenzie CR; Pryzdial EL
    Biochemistry; 2001 May; 40(21):6293-302. PubMed ID: 11371191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effect of platelets on plasminogen activation by tissue plasminogen activator, urokinase, and streptokinase.
    Gao SW; Morser J; McLean K; Shuman MA
    Thromb Res; 1990 May; 58(4):421-33. PubMed ID: 2112791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmin desensitization of the PAR1 thrombin receptor: kinetics, sites of truncation, and implications for thrombolytic therapy.
    Kuliopulos A; Covic L; Seeley SK; Sheridan PJ; Helin J; Costello CE
    Biochemistry; 1999 Apr; 38(14):4572-85. PubMed ID: 10194379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of plasmin-induced platelet aggregation.
    Watabe A; Ohta M; Matsuyama N; Mizuno K; el Borai N; Tanimoto T; Kawanishi T; Hayakawa T
    Res Commun Mol Pathol Pharmacol; 1997 Jun; 96(3):341-52. PubMed ID: 9261893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.